Study of TQB3205 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an experimental drug called TQB3205 for people with advanced solid tumors that have not responded to other treatments. The study will check if the drug is safe and how it affects the tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have advanced solid tumors with at least one measurable tumor.
- Your overall health is good (able to do daily activities).
- Your main organs (like liver, kidneys, bone marrow) are working well enough.
- You are not pregnant and agree to use effective birth control during and for 6 months after the study.
- You have not had major surgery or a serious infection in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental oral capsule called TQB3019 for people with advanced blood cancers that have come back or not improved with other treatments. The goal is to see if the drug is safe and to find the right dose.
This study tests an experimental pill called TQB3217 for people with advanced solid tumors that haven't responded to usual treatments. The goal is to see if the pill is safe, how it works in the body, and whether it helps shrink or slow the cancer.
This trial tests an experimental oral capsule (TQB3122) for safety and early signs of effectiveness in people with advanced solid tumors that have not responded to standard therapies. It is for patients who are relatively healthy and have specific cancer types like ovarian, breast, or prostate cancer.
This trial tests a new drug, TQB6411, for people with advanced cancers that have not responded to standard treatments. It aims to see if the drug is safe and effective for different tumor types.
This study tests an investigational drug called TQB2922, given as an injection under the skin, for people with advanced non-small cell lung cancer that has not improved with standard treatments. The goal is to see if the drug is safe and helpful.
This study tests a new injection called TQB2930 designed to treat advanced solid cancers (cancers that have spread) that have HER2 protein on their surface. The goal is to see if this treatment can shrink these tumors and help patients live longer.
Hear when a new Advanced Malignant Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.